High Dose Methylprednisolone (HDMP)

DRUG2 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute

Conditions

Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma

Phase 2

Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

CompletedNCT01497496

H. Lee Moffitt Cancer Center and Research InstituteChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2012-01-26End: 2020-03-20Updated: 2021-04-27

Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL

CompletedNCT01496976

H. Lee Moffitt Cancer Center and Research InstituteChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2012-03-30End: 2024-09-11Updated: 2025-12-19